221 related articles for article (PubMed ID: 7508102)
1. The diagnostic use of low molecular weight keratin expression in sebaceous carcinoma.
Murata T; Nakashima Y; Takeuchi M; Sueishi K; Inomata H
Pathol Res Pract; 1993 Sep; 189(8):888-93. PubMed ID: 7508102
[TBL] [Abstract][Full Text] [Related]
2. Immunolabeling pattern of cytokeratin 19 expression may distinguish sebaceous tumors from basal cell carcinomas.
Heyl J; Mehregan D
J Cutan Pathol; 2008 Jan; 35(1):40-5. PubMed ID: 18095993
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
Yang HM; Cabral E; Dadras SS; Cassarino DS
Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical study of sebaceous carcinoma with anti-keratin monoclonal antibodies: comparison with other skin cancers.
Ansai S; Katagata Y; Yoshikawa K; Hashimoto H; Hozumi Y; Kondo S; Aso K
J Dermatol; 1994 Aug; 21(8):553-9. PubMed ID: 7525677
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical findings of sebaceous carcinoma and sebaceoma: retrieval of cytokeratin expression by a panel of anti-cytokeratin monoclonal antibodies.
Ansai S; Arase S; Kawana S; Kimura T
J Dermatol; 2011 Oct; 38(10):951-8. PubMed ID: 21592202
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of adipophilin immunostain in periocular carcinomas.
Milman T; Schear MJ; Eagle RC
Ophthalmology; 2014 Apr; 121(4):964-71. PubMed ID: 24290802
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry in ocular carcinomas.
Sramek B; Lisle A; Loy T
J Cutan Pathol; 2008 Jul; 35(7):641-6. PubMed ID: 18201230
[TBL] [Abstract][Full Text] [Related]
8. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study.
Plaza JA; Mackinnon A; Carrillo L; Prieto VG; Sangueza M; Suster S
Am J Dermatopathol; 2015 Nov; 37(11):809-21. PubMed ID: 26485238
[TBL] [Abstract][Full Text] [Related]
9. Sebaceous carcinoma, basal cell carcinoma, trichoadenoma, trichoblastoma, and syringocystadenoma papilliferum arising within a nevus sebaceus.
Miller CJ; Ioffreda MD; Billingsley EM
Dermatol Surg; 2004 Dec; 30(12 Pt 2):1546-9. PubMed ID: 15606837
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
Morgan MB; Purohit C; Anglin TR
Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
[TBL] [Abstract][Full Text] [Related]
11. Frequent TLE1 Expression in Cutaneous Neoplasms.
Xiong Y; Dresser K; Cornejo KM
Am J Dermatopathol; 2019 Jan; 41(1):1-6. PubMed ID: 30608261
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous cell carcinoma.
Sinard JH
Arch Ophthalmol; 1999 Jun; 117(6):776-83. PubMed ID: 10369589
[TBL] [Abstract][Full Text] [Related]
13. Dimorphic immunohistochemical staining in ocular sebaceous neoplasms: a useful diagnostic aid.
Johnson JS; Lee JA; Cotton DW; Lee WR; Parsons MA
Eye (Lond); 1999; 13 ( Pt 1)():104-8. PubMed ID: 10396393
[TBL] [Abstract][Full Text] [Related]
14. Distinction of benign sebaceous proliferations from sebaceous carcinomas by immunohistochemistry.
Cabral ES; Auerbach A; Killian JK; Barrett TL; Cassarino DS
Am J Dermatopathol; 2006 Dec; 28(6):465-71. PubMed ID: 17122489
[TBL] [Abstract][Full Text] [Related]
15. Sebaceous carcinoma: an immunohistochemical reappraisal.
Ansai S; Takeichi H; Arase S; Kawana S; Kimura T
Am J Dermatopathol; 2011 Aug; 33(6):579-87. PubMed ID: 21778832
[TBL] [Abstract][Full Text] [Related]
16. Low-grade sebaceous carcinoma presenting on the leg.
Imakado S; Hamada K; Miura K
Am J Dermatopathol; 2008 Dec; 30(6):608-11. PubMed ID: 19033940
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical study on keratin of squamous cell carcinoma of the uterine cervix].
Nagata J; Okabe K; Negishi Y; Takayama M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jan; 44(1):33-40. PubMed ID: 1371799
[TBL] [Abstract][Full Text] [Related]
18. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.
Schmitz EJ; Herwig-Carl MC; Holz FG; Loeffler KU
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159
[TBL] [Abstract][Full Text] [Related]
19. Lipid synthesis and processing proteins ABHD5, PGRMC1 and squalene synthase can serve as novel immunohistochemical markers for sebaceous neoplasms and differentiate sebaceous carcinoma from sebaceoma and basal cell carcinoma with clear cell features.
Chen WS; Chen PL; Li J; Lind AC; Lu D
J Cutan Pathol; 2013 Jul; 40(7):631-8. PubMed ID: 23557589
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of survivin in cutaneous sebaceous lesions.
Calder KB; Khalil FK; Schlauder S; Cualing HD; Morgan MB
Am J Dermatopathol; 2008 Dec; 30(6):545-8. PubMed ID: 19033926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
